Stay updated on Pfizer Press Releases
Sign up to get notified when there's something new on the Pfizer Press Releases page.
Latest updates to the Pfizer Press Releases page
- ChecktodayChange DetectedPfizer has voluntarily withdrawn all lots of its sickle cell disease treatment OXBRYTA® from worldwide markets, while also receiving a positive CHMP opinion for its Omicron-adapted COVID-19 vaccine in the EU.SummaryDifference32%
- Check8 days agoChange DetectedPfizer will present its scientific advancements in respiratory and infectious diseases at IDWeek 2024, while the announcement of top-line results for ABRYSVO® in immunocompromised adults has been removed.SummaryDifference8%
- Check15 days agoChange DetectedPfizer has voluntarily withdrawn all lots of its sickle cell disease treatment OXBRYTA® from worldwide markets.SummaryDifference9%
- Check22 days agoChange DetectedPfizer's recent updates include a positive CHMP opinion for their Omicron-adapted COVID-19 vaccine and an invitation to a webcast for an upcoming conference call, while notable deletions include the approval of a gene therapy for Hemophilia B and positive results from a Hemophilia A gene therapy study.SummaryDifference21%
- Check164 days agoChange DetectedThe webpage now shows that Pfizer has announced a new Chief Strategy and Innovation Officer on 05.06.2024, indicating a significant leadership change within the company.SummaryDifference100%
- Check169 days agoChange DetectedThe value on the webpage has changed to 05.01.2024, indicating that Pfizer has reported its First-Quarter 2024 Results. This change likely represents a significant announcement or press release regarding Pfizer's financial performance for the first quarter of 2024.SummaryDifference43%
Stay in the know with updates to Pfizer Press Releases
Enter your email address, and we'll notify you when there's something new on the Pfizer Press Releases page.